Ayvakit 25 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F65M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,360
Award facts
- Contract value 100% obligated
- $26,359.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Ayvakit (25 mg tablets, 30-count package). This firm fixed-price, non-set-aside contract carries a ceiling value of $26,359.88 with an ultimate completion date of February 4, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order supports the Defense Logistics Agency's mission to provide critical pharmaceutical commodities to military treatment facilities and veteran healthcare systems. Ayvakit (avapritinib) is a specialty oncology medication used in the treatment of gastrointestinal stromal tumors, reflecting the breadth of therapeutic areas covered under the DLA's pharmaceutical procurement strategy. AmerisourceBergen's extensive federal contracting history and established position as a prime pharmaceutical vendor for military healthcare systems demonstrate the company's capability to efficiently fulfill government requirements for essential medical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F65M1?
SPE2DR26F65M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F65M1 worth?
The government has obligated $26,360 on SPE2DR26F65M1.
Is contract SPE2DR26F65M1 an order under another contract?
Yes. SPE2DR26F65M1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65M1 competed?
The extent of competition for SPE2DR26F65M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award